Skip to content
Screener

United Therapeutics UTHR Shares (Diluted)

Shares (Diluted) at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
84M-8.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Insmed logo
InsmedINSM
215.5M+19.1%
Ethos Technologies, Inc. logo
Ethos Technologies, Inc. LIFE
98M+13.4%
LQD
Liquidia CorporationLQDA
101.1M+18.7%
Amgen logo
AmgenAMGN
544M+0.6%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M—
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$21.98B+66.0%
P/E17.1×+6.4×
P/S6.9×+2.6×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity0×—
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: United Therapeutics’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 6:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001082554-26-000020
Line itemThree Months Ended March 31, 20262025
Income tax expense(43.4)(101.3)
Net income$274.9$322.2
Net income per common share:
Basic$6.32$7.18
Diluted$5.82$6.63
Weighted average number of common shares outstanding:
Basic43.544.9
Diluted47.248.6

Item 1. Consolidated Financial Statements

FAQ

What is United Therapeutics's shares (diluted)?
United Therapeutics (UTHR) reported shares (diluted) of 47.2M in Q1 2026.
How has United Therapeutics's shares (diluted) changed year-over-year?
United Therapeutics's shares (diluted) decreased by 2.9% year-over-year, from 48.6M to 47.2M.
What is the long-term trend for United Therapeutics's shares (diluted)?
Over 4 years (2021 to 2025), United Therapeutics's shares (diluted) has grown at a 0.5% compound annual growth rate (CAGR), from 188.6M to 192.1M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about United Therapeutics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude